-+ 0.00%
-+ 0.00%
-+ 0.00%

Alto Neuroscience Promotes Nick Smith To President, CFO, Effective Aug. 26

Benzinga·08/27/2026 20:09:50
Listen to the news

Alto Neuroscience, Inc. (NYSE: ANRO), a clinical-stage biopharmaceutical company developing novel precision medicines for neuropsychiatric disorders, today announced the promotion of Nick Smith to president and chief financial officer, effective August 26, 2026.